Home » Posts tagged 'NOVUS COMMUNICATIONS CEO ALAN GREEN'

Tag Archives: NOVUS COMMUNICATIONS CEO ALAN GREEN

Alan Green talks Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES on the Vox Markets podcast

Alan Green discusses Synairgen #SNG, OnTheMarket #OTMP, ECR Minerals #ECR & Blencowe Resources #BRES with Justin Waite on the Vox Markets podcast. Interview is 14 minutes in.

Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk

Alan Green presents the investment case for Synairgen #SNG, Omega Diagnostics #ODX, Open Orphan #ORPH & Venture Life #VLG on his weekly Stockbox Media Research talk.

Alan Green talks markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST on UK Investor Magazine podcast

Alan Green discusses markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST with Jonathan Roy on the UK Investor Magazine podcast.

Alan Green talks to Venture Life Group #VLG CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University.

Alan Green talks to Venture Life Group (AIM: VLG) CCO Sharon Collins about the results of the groundbreaking COVID Mouthwash trial at Cardiff University. Sharon also discusses the group progress to date in 2020, and summarises the current investment proposition for investors

Alan Green talks Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast

Alan Green discusses Venture Life Group #VLG, RA International #RAI & Arkle Resources #ARK on Vox Markets podcast. Interview is 14 minutes 45 seconds in.

Alan Green presents the investment case for Kavango Resources #KAV and Bidstack #BIDS on his weekly Stockbox Media Research talk

Alan Green presents the investment case for Kavango Resources #KAV and Bidstack #BIDS on his weekly Stockbox Media Research talk

Alan Green talks COVID stocks Novacyt #NCYT), Synairgen #SNG, Avacta #AVCT, plus Blue Prism #PRSM & Capita #CPI on the UK Investor Magazine podcast

The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020.

The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward.

We discuss Novacyt (NCYT), Synairgen (SNG), Avacta (AVCT), Blue Prism (PRSM) and Capita (CPI).

Alan Green talks Mirriad #MIRI, Ixico #IXI, Conroy Gold #CGNR & Keras Resources #KRS on Vox Markets podcast

Alan Green discusses Mirriad #MIRI, Ixico #IXI, Conroy Gold #CGNR & Keras Resources #KRS on Vox Markets podcast. Interview is 9 minutes in.

Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA

Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA

Alan Green talks Keras Resources #KRS, Blencowe Resources #BRES & Cadence Minerals #KDNC on the UK Investor Magazine podcast

Alan Green discusses Keras Resources #KRS, Blencowe Resources #BRES & Cadence Minerals #KDNC with Jonathan Roy on the UK Investor Magazine podcast

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.